Abstract

Compared to the general population, insomnia is three to five times more prevalent in patients during and after cancer treatment. Reasons for this increased prevalence include the impact of the disease itself, the emotional consequences of a cancer diagnosis, and the short- and long-term side effects of cancer treatment. In this chapter, the conceptualization of insomnia in cancer survivors is reviewed, the evidence for the efficacy of cognitive-behavioral therapy for insomnia (CBT-I) in cancer survivors is presented, and recommendations are provided for how to adapt CBT-I for use with patients who are undergoing or have completed cancer treatment.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.